Schröper, Tobias
Mehrkens, Dennis
Leiss, Veronika
Tellkamp, Frederik
Engelhardt, Stefan
Herzig, Stefan
Birnbaumer, Lutz
Nürnberg, Bernd
Matthes, Jan
Funding for this research was provided by:
Graduate Program in Pharmacology and Experimental Therapeutics of the University of Cologne and Bayer Schering Pharma (C25, C25)
Deutsche Forschungsgemeinschaft (TRR 259 (397484323), NU 53/9-2, NU 53/9-2)
Intramural Research Program of the NIH (Z01-ES-101643)
Universitätsklinikum Köln
Article History
Received: 8 August 2023
Accepted: 26 September 2023
First Online: 16 October 2023
Declarations
:
: The manuscript does not contain clinical studies or patient data. The responsible federal state authority approved animal breeding, maintenance, and experiments (Landesamt fuer Natur-, Umwelt- und Verbraucherschutz Nordrhein-Westfalen; references: 84–02.05.20.12.294, 84–02.05.20.13.060, and 84–02.04.2016.A422). All animal experiments complied with the guidelines from Directive 2010/63/EU of the European Parliament on the protection of animals used for scientific purposes.
: The authors declare no competing interests.